November 08, 2021
4 min watch
Save
VIDEO: Ask about dry eye flares during routine exams
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
BOSTON – The majority of subjects surveyed indicated they experienced a dry eye flare at least once during a 12-month period, according to a poster at the American Academy of Optometry annual meeting.
“We should ask patients about these flares and what they’re doing to manage them when they’re occurring,” co-author Kelly K. Nichols, OD, MPH, PhD, FAAO, said. Of the nearly 2,000 adults surveyed, about 80% “reported they wanted something more effective than what they were doing when they were having flares.”
Published by:
Sources/Disclosures
Collapse
Disclosures:
Nichols reports consulting for Allergan/Abbvie, Axim, Bausch + Lomb, Bruder, Dompé, HanAll Bio, Kala Pharmaceuticals, Novartis, Osmotica/RVL, Oyster Point Pharma, Sight Sciences, Sun, Tarsus, Thea, Topivert and Visionology. She reports receiving grants/research support from Allergan, Kala Pharmaceuticals, NIH and Tear Science. She reports owning stock or holding shares in Alcon Vision/Tear Film Innovations, Axim and Visionology.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.